Latest Breaking News On - Innovative drug development - Page 8 : comparemela.com

CORRECTION FROM SOURCE: Virogentics Announces Approval of Final Protocol from the Dept for HIV and AIDS, Ministry of Health of the DRC

CORRECTION FROM SOURCE: Virogentics Announces Approval of Final Protocol from the Dept for HIV and AIDS, Ministry of Health of the DRC
newjerseytelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newjerseytelegraph.com Daily Mail and Mail on Sunday newspapers.

Addis ababaUnited statesDemocratic republic of the congoSud kivuUnited kingdomDemocratic republic of the generalBarry kostinerHarry zhabiovAmogne wondwossenWhile enzolytics incSchool of medicineVirogentics incNeuro pharma ltdUniversity of dundeeInnovative drug developmentDrug administration

World Mental Health Day 2022: Mental Health for All

News-Medical speaks to Prof. Charlotte Hanlon, psychiatrist and researcher, about her work within the field of Global Mental Health and the importance of raising awareness around this year's theme, "Make mental health and wellbeing for all a global priority."

United statesUnited kingdomAddis ababaSouth africaCity ofSri lankaAmina abubakerLeadersprofessor charlotte hanlonLightspring shutterstockLaura asherRitsuko kakumaGraham thornicroftVikram patelRosa hoekstraDragana gordic shutterstockDanielle ellis

Simcere agree license deal of $492M USD with Almirall

Almirall granted exclusive rights to commercialise SIM0278 for all indications outside the Greater China region, (Mainland China, Hong Kong, Macau and Taiwan)

Hong kongUnited statesComunidad autonoma de catalunaRenhong tangKarl ziegelbauerInnovative pharmaceutical enterprisesSimcere pharmaceutical groupInnovative drug developmentManufacturing enterprises of chinaSpanish stock exchangeKey laboratory of translational medicineGreater chinaMainland chinaPharmaceutical groupChief scientificPharmaceutical group limited

Tamas Oravecz Ph D named SVP, CSO of the U S of Simcere Pharmaceutical Group

/PRNewswire/ Simcere Pharmaceutical Group announces today the appointment of Tamas Oravecz, Ph.D. as Senior Vice President, Chief Scientific Officer of the.

United statesTamas oraveczSimcere us tamasRenghong tangProgram headSimcere pharmaceutical groupDrug administrationUniversity of szeged hungaryBritish council imperial cancer research fundResearch centerKey laboratory of translational medicineNational institutes of health us foodSwiss society for immunologyFogarty international center national institutes of healthPrnewswire simcere pharmaceutical groupHungarian academy of sciences

Simcere Pharmaceutical Announces Financial Results for 2022 H1: 27% Year-Over-Year Revenue Growth, with Innovative Drugs Accounting for 65 4% of Total Revenue

/PRNewswire/ Simcere Pharmaceutical Group Limited (2096.HK) announced its financial results for the first half of 2022. As of June 30, Simcere recorded.

United statesHong kongPrnewswire simcere pharmaceutical groupHong kong stock exchangeSimcere pharmaceutical groupSimcere pharmaceuticalInnovative drug developmentKey laboratory of translational medicinePharmaceutical group limitedDrug evaluationState key laboratoryTranslational medicinePharmaceutical groupSimcere pharmaceutical group limited